Skip to content

Evaluating iCare COMPASS as a Visual Field Diagnostic Tool

Evaluating iCare COMPASS as a Visual Field Diagnostic Tool

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07765147
Enrollment
28
Registered
2026-08-14
Start date
2025-02-07
Completion date
2026-01-16
Last updated
2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GLAUCOMA 1, OPEN ANGLE, D (Disorder)

Keywords

GLAUCOMA

Brief summary

this study seeks to compare the Humphrey Visual Field Analyzer and iCare COMPASS for both clinical accuracy and operational advantages.

Interventions

DIAGNOSTIC_TESTVISUAL FIELD TESTING

This study will be a crossover study. Patients who express interest in taking part in the study will be evaluated using Humphrey SITA-faster, which is the current standard of care for visual perimetry, and the iCare COMPASS in the same visit. Participants will be assigned to one of two groups of alternating testing order with the Humphrey Visual Field Analyzer vs the iCare COMPASS and vice versa. The mean deviation, pattern standard deviation, mean deviation cluster, and fixation plot results will be compared. For analysis, participants will be grouped according to the inclusion criteria.

Sponsors

Indiana University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All consenting patients who arrive for glaucoma management appointments for objective(s) 2.1.1, 2.2.2 * Patient groups arriving for glaucoma management that will be targeted for enrollment include: glaucoma suspect patients, those with cataracts, optic atrophy, macular degeneration, macular pathology, and vascular diseases of the retina

Exclusion criteria

* Those who are unwilling or unable to provide consent * Those for which English is not their first language

Design outcomes

Primary

MeasureTime frameDescription
Visual Fields will be assessed via the current standard of care Humphrey SITA-Faster when available. The mean deviation, pattern standard deviation, mean deviation cluster, and fixation plot obtained will be compared with the same measures on the iCarewithin 1-3 months post visitTesting will be performed with either one or two encounters with the patient or as determined by the patients' clinician.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMASOOD MOHAMMADI, MD

Indiana University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 15, 2026